BioNexus Gene Lab Corp.

NASDAQ (USD): BioNexus Gene Lab Corp. (BGLC)

Last Price

0.361

Today's Change

-0.10 (21.69%)

Day's Change

0.345 - 0.46

Trading Volume

1,176,917

Profile
BGLC

Exchange:  NASDAQ Capital Market NASDAQ Capital Market

Currency:  USD USD

Sector:  Healthcare - Healthcare Healthcare - Healthcare

Industry: 

CEO:  Mr. Su-Leng Tan Mr. Su-Leng Tan

Full Time Employees:  30 30

IPO Date:  2021-01-08 2021-01-08

CIK:  0001737523 0001737523

ISIN:  US0906282076 US0906282076

CUSIP:  090628108 090628108

Beta:  1.87 1.87

Last Dividend:  0.00 0.00

Dcf Diff:  0.00 0.00

Dcf:  0.00 0.00

Description

BioNexus Gene Lab Corp., through its subsidiary, Chemrex Corporation Sdn. Bhd., engages in the wholesale of chemical raw material products in Malaysia, Indonesia, Vietnam, and other countries in Southeast Asia. Its chemical raw material products used to produce handrails, bench tops, automotive and aero parts, cleanroom panels, and instruments. The company, through its subsidiary, BioNexus Gene Lab Sdn. Bhd, is also involved in developing and providing non-invasive liquid biopsy tests for the early detection of biomarkers. The company was incorporated in 2017 and is based in Kuala Lumpur, Malaysia.

Address

Tower B, Vertical Business Suite,
Kuala Lumpur, 59200, MY

60 1 2212 6512

http://www.bionexusgenelab.com

Discussions
Be the first to like this. Showing 0 of 0 comments
Post a Comment